ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995

U of Pittsburgh Wins NCI Grant To Include End-of-Life Issues In Med. School Curriculum.

July 6, 2001

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993